Familial Nasopharyngeal Carcinoma 6

Prognostic Factors in Nasopharyngeal Cancer 135Raab-Traub N, Flynn K (1986) The structure of the termini ofthe Epstein–Barr virus as a marker of clonal cellular proliferation.Cell 47:883–889Ramakrishnan Y, Paleri V, Shah R, Steen IN, Wight RG, KellyCG (2007) Comorbidity in nasopharyngeal carcinoma: apreliminary communication on the prevalence, descriptivedistribution and impact on outcome. Clin Otolaryngol32:484–488Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE(1995) Prognostic significance of keratinization innasopharyngeal carcinoma. Am J Otolaryngol 16:103–108Rossi A, Molinari R, Boracchi P, Del Vecchio M, Marubini E,Nava M, Morandi L, Zucali R, Pilotti S, Grandi C, et al (1988)Adjuvant chemotherapy with vincristine, cyclophosphamide,and doxorubicin after radiotherapy in local-regionalnasopharyngeal cancer: results of a 4-year multicenter randomizedstudy. J Clin Oncol 6:1401–1410Roychowdhury DF, Tseng A Jr, Fu KK, Weinburg V, Weidner N(1996) New prognostic factors in nasopharyngeal carcinoma.Tumor angiogenesis and C-erbB2 expression.Cancer 77:1419–1426Rubio L, Burgos JS, Morera C, Vera-Sempere FJ (2000)Morphometric study of tumor angiogenesis as a new prognosticfactor in nasopharyngeal carcinoma patients. PatholOncol Res 6:210–216Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, MorrisonWH, Peters LJ (1997) Carcinoma of the nasopharynx treatedby radiotherapy alone: determinants of local and regionalcontrol. Int J Radiat Oncol Biol Phys 37:985–996Santos JA, González C, Cuesta P, de la Fuente I, Carrión JR(1995) Impact of changes in the treatment of nasopharyngealcarcinoma: an experience of 30 years. Radiother Oncol36:121–127Sakata K, Hareyama M, Tamakawa M, Oouchi A, Sido M,Nagakura H, Akiba H, Koito K, Himi T, Asakura K (1999)Prognostic factors of nasopharynx tumors investigated byMR imaging and the value of MR imaging in the newlypublished TNM staging. Int J Radiat Oncol Biol Phys43:273–278Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, SacksN, Bender HG, Luqmani Y, Coombes RC (1997) The detectionof micrometastases in the peripheral blood and bonemarrow of patients with breast cancer using immunohistochemistryand reverse transcriptase polymerase chainreaction for keratin 19. Eur J Cancer 33:854–861Sham JS, Choy (1991) Prognostic value of parapharyngealextension of nasopharyngeal carcinoma on local controland short-term survival. Head Neck 13:298–310Shanmugaratnam K, Sobin LH (1993) The World HealthOrganization histological classification of tumors of theupper respiratory tract and ear. A commentary on the secondedition. Cancer 71:2689–2697Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF,Ernberg I, Zeng YX (2004) Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulinA/virus capsid antigen antibody titers in patients withnasopharyngeal carcinoma. Cancer 100:1162–1170Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He S (2008) Prognostic impactof primary tumor volume in patients with nasopharyngealcarcinoma treated by definitive radiation therapy.Laryngoscope 118:1206–1210Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W,Voravud N, Mutirangura A (2000) Epstein–Barr virus DNAin serum/plasma as a tumor marker for nasopharyngealcancer. Clin Cancer Res 6:1046–1051Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE(1991) Detection of melanoma cells in peripheral blood bymeans of reverse transcriptase and polymerase chain reaction.Lancet 338:1227–1229Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Verderio P,Pastorino U (2005) Effects of prolonged storage of wholeplasma or isolated plasma DNA on the results of circulatingDNA quantification assays. J Natl Cancer Inst 97:1848–1850Su CK, Wang CC (2002) Prognostic value of Chinese race innasopharyngeal cancer. Int J Radiat Oncol Biol Phys54:752–758Sun LM, Li CI, Huang EY, Vaughan TL (2007) Survival differencesby race in nasopharyngeal carcinoma. Am J Epidemiol165:271–278Sundram FX, Aw SE (1986) Tissue polypeptide antigen (TPA) andb2-microglobulin (b2-MG) as tumor markers in nasopharyngealcancer. Ann Acad Med Singapore 15:507–510Sze WM, Lee AW, Yau TK, Yeung RM, Lau KY, Leung SK, HungAW, Lee MC, Chappell R, Chan K (2004) Primary tumor volumeof nasopharyngeal carcinoma: prognostic significanceof local control. Int J Radiat Oncol Biol Phys 59:21–27Tang L, Li L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, Liao X, Tian L,Lin A, Liu M, Ma J (2008) Retropharyngeal lymph nodemetastasis in nasopharyngeal carcinoma detected by magneticresonance imaging. Cancer 113:347–354Teo PM, Lee WY, Yu P (1996) The prognostic significance ofparapharyngeal tumor involvement in nasopharyngealcarcinoma. Radiother Oncol 39:209–221Teo PM, Leung SF, Lee WY, Zee B (2000a) Intracavitarybrachytherapy significantly enhances local control of earlyT-stage nasopharyngeal carcinoma: the existence of a dosetumor-controlrelationship above conventional tumoricidaldose. Int J Radiat Oncol Biol Phys 46:445–458Teo PM, Leung SF, Chan AT, Leung TW, Choi PH, Kwan WH, LeeWY, Chay RM, Yu PK, Johnson PJ (2000b) Final report of arandomized trial on altered-fractionated radiotherapy innasopharyngeal carcinoma prematurely terminated by significantincrease in neurologic complications. Int J RadiatOncol Biol Phys 48:1311–1322Tsai ST, Jin YT, Su IJ (1996) Expression of EBER1 in primaryand metastatic nasopharyngeal carcinoma tissues using insitu hybridization. A correlation with WHO histologic subtypes.Cancer 77:231–236Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL (2007) Serumlactate dehydrogenase level is a prognostic factor in patientswith locoregionally advanced nasopharyngeal carcinomatreated with chemoradiotherapy. Cancer Invest 25:315–321Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT,Lin JC (2007) Comparison the prognostic impact of serumAnti-EBV antibody and plasma EBV DNA assays in nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 67:130–137Uen WC, Luka J, Pearson GR (1988) Development of anenzyme-linked immunosorbent assay (ELISA) for detectingIgA antibodies to the Epstein–Barr virus. Int J Cancer41:479–482Vikram B, Mishra UB, Strong EW, Manolatos S (1985) Patternsof failure in carcinoma of the nasopharynx: I. Failure at theprimary site. Int J Radiat Oncol Biol Phys 11:1455–1459Wang CC (1989) Accelerated hyperfractionation radiationtherapy for carcinoma of the nasopharynx. Techniques andresults. Cancer 63:2461–2467